rosiglitazone has been researched along with Brain Infarction in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballesteros, I; Caso, JR; Fernández-López, D; Hurtado, O; Lizasoain, I; Moro, MA; Nombela, F; Pereira, MP; Pradillo, JM; Serena, J; Sobrado, M; Vivancos, J | 1 |
| Allahtavakoli, M; Arababadi, MK; Javanmardi, K; Moloudi, R; Shamsizadeh, A | 1 |
| Cheng, FC; Cheng, SM; Chou, CC; Chuang, HC; Lee, MR; Sheu, WH | 1 |
| Allahtavakoli, M; Djahanguiri, B; Parviz, M; Sadr, SS; Shabanzadeh, AP | 1 |
4 other study(ies) available for rosiglitazone and Brain Infarction
| Article | Year |
|---|---|
Synthesis of lipoxin A4 by 5-lipoxygenase mediates PPARgamma-dependent, neuroprotective effects of rosiglitazone in experimental stroke.
Topics: Animals; Arachidonate 5-Lipoxygenase; Brain; Brain Infarction; Infarction, Middle Cerebral Artery; Leukotriene B4; Lipoxins; Mice; Neuroprotective Agents; PPAR gamma; Rats; Rosiglitazone; Stroke; Thiazolidinediones | 2009 |
Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.
Topics: Animals; Brain Infarction; Brain Ischemia; Cell Death; Disease Models, Animal; DNA Fragmentation; Encephalitis; Hypoglycemic Agents; Infarction, Middle Cerebral Artery; Leukocyte Count; Male; Neuroprotective Agents; Neutrophils; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Time Factors; Treatment Outcome | 2009 |
Microdialysis combined blood sampling technique for the determination of rosiglitazone and glucose in brain and blood of gerbils subjected to cerebral ischemia.
Topics: Animals; Automation, Laboratory; Blood Glucose; Brain; Brain Infarction; Brain Ischemia; Gerbillinae; Glucose; Half-Life; Hypoglycemic Agents; Limit of Detection; Male; Microdialysis; PPAR gamma; Random Allocation; Reperfusion Injury; Reproducibility of Results; Rosiglitazone; Tandem Mass Spectrometry; Thiazolidinediones; Tissue Distribution | 2011 |
Rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, reduces infarction volume and neurological deficits in an embolic model of stroke.
Topics: Animals; Behavior, Animal; Brain Edema; Brain Infarction; Dose-Response Relationship, Drug; Fibrinolytic Agents; PPAR gamma; Rats; Rosiglitazone; Stroke; Thiazolidinediones; Time Factors | 2006 |